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ABSTRACT
Reprogramming of cancer cells into induced pluripotent stem cells (iPSCs) is a compelling idea for
inhibiting oncogenesis, especially through modulation of homeobox proteins in this reprogramming
process. We examined the role of various long noncoding RNAs (lncRNAs)-homeobox protein HOXA13
axis on the switching of the oncogenic function of bone morphogenetic protein 7 (BMP7), which is sig-
nificantly lost in the gastric cancer cell derived iPS-like cells (iPSLCs). BMP7 promoter activation
occurred through the corecruitment of HOXA13, mixed-lineage leukemia 1 lysine N-methyltransferase,
WD repeat-containing protein 5, and lncRNA HoxA transcript at the distal tip (HOTTIP) to commit the
epigenetic changes to the trimethylation of lysine 4 on histone H3 in cancer cells. By contrast, HOXA13
inhibited BMP7 expression in iPSLCs via the corecruitment of HOXA13, enhancer of zeste homolog 2,
Jumonji and AT rich interactive domain 2, and lncRNA HoxA transcript antisense RNA (HOTAIR) to vari-
ous cis-element of the BMP7 promoter. Knockdown experiments demonstrated that HOTTIP contrib-
uted positively, but HOTAIR regulated negatively to HOXA13-mediated BMP7 expression in cancer
cells and iPSLCs, respectively. These findings indicate that the recruitment of HOXA13–HOTTIP and
HOXA13–HOTAIR to different sites in the BMP7 promoter is crucial for the oncogenic fate of human
gastric cells. Reprogramming with octamer-binding protein 4 and Jun dimerization protein 2 can inhibit
tumorigenesis by switching off BMP7. STEMCELLS 2017;35:2115–2128
SIGNIFICANCE STATEMENT
Reprogramming of the gastric cancer cells is a challengeable approach for therapeutic use.
Here we report the successful reprogramming of the human gastric cells into induced pluripo-
tent stem cell–like cells (iPSLCs) using Jun dimerization protein 2 (JDP2) and octamer-binding
protein 4 (OCT4). The oncogenic function of Bone morphogenetic protein 7 (BMP7) is switched
by long noncoding RNA–HOXA13 axis and lost in the gastric cancer cell-derived iPSLCs. The
recruitment of HOXA13–HoxA transcript at the distal tip (HOTTIP) complex and HOXA13–HoxA
transcript antisense RNA (HOTAIR) complex to different sites in the BMP7 promoter is critical
for the oncogenic fate of human gastric cells. Thus, reprogramming with OCT4 and JDP2 can
inhibit tumorigenic function by switching off BMP7.
INTRODUCTION
The gene for homeobox protein HOXA13
(HOXA13) is located as the most-posterior
gene of the HOXA cluster in 7p15.2 [1].
Expression of HOXA13 is important for homeo-
stasis in morphogenesis [1]. HOXA13 has a
role in cancer promotion of liver stem-like cell
lines [2] and the growth of esophageal cancer
[3], and is involved in hepatocarcinogenesis [4]
and leukemogenesis [5]. Moreover, HOXA13 is
a poor prognostic marker for gastric cancer
patients [6]. Recently we found that upregula-
tion of HOXA13 plays a critical role in the
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tumorigenesis of gastric cancer by comparing the nontumori-
genic gastric cell line CSN and its derivative cancerous subline
CS12 [7].
HOXA13 is reported to directly control the expression of
bone morphogenetic protein 7 (BMP7) via binding to its
enhancer element [8, 9]. BMP7 is a multifunctional growth fac-
tor belonging to the transforming growth factor beta superfam-
ily. In addition to its function in bone formation and cartilage
development, BMP7 is relevant in cell proliferation, apoptosis,
and organ regulation and repair. In cancer, BMP7 behaves as an
oncogene [10] or anti-oncogene [11] depending on ligands and
cell types [12].
The long noncoding RNA (lncRNA) HOXA transcript at the
distal tip (HOTTIP), located at the 50-end of the HOXA cluster,
is expressed signiﬁcantly in anatomically distal human ﬁbro-
blasts [13]. The interaction of the HOTTIP and WD repeat-
containing protein 5 (WDR5)/mixed-lineage leukemia 1 lysine
N-methyltransferase (MLL1 also known as histone-lysine N-
methyltransferase 2A or KMT2A) in Tithorax complex enhan-
ces histone H3 lysine 4 trimethylation (H3K4me3) to activate
the expression of 50-HOXA genes including HOXA13 [14, 15].
Increased HOTTIP expression is a negative prognostic factor in
some cancers [16] and promotes tumor progression and drug
resistance by regulating HOXA13 in pancreatic cancer [17].
Another lncRNA HOTAIR is expressed from the posterior
region of the HOXC11–12 cluster and is implicated in cancer
development. HOTAIR interacts with enhancer of zeste homo-
log 2 (EZH2), suppressor of zeste 12 homolog subunit (SUZ12)
in Polycomb repressive complex 2, and lysine demethylase 1A
(LSD1 or KDM1A) to mediate repressive histone modiﬁcations
at H3K27 and H3K4 at posterior HOXD locus [18, 19]. Thus,
the actions of HOTTIP and HOTAIR to HOXA13 and HOXD10
loci are cis and trans, respectively [14, 15, 18, 19]. However,
to our knowledge no common targets, which are regulated by
both lncRNAs are present previously and the mechanistic reg-
ulation of the lncRNAs-HOX axis on their target remains to be
clariﬁed [20].
We have shown that the Jun dimerization protein 2 (JDP2) is
a modulator of wingless-related integration site signaling path-
way [21] and works together with octamer-binding protein 4
(OCT4) for the reprogramming of medulloblastoma to generate
induced pluripotent stem cell (iPSC)-like cells (iPSLCs) [22]. Liu
et al. [23] also reported that JDP2 reprograms the somatic cells
into the iPSCs through the ﬁve non-Yamanaka factors (Id1,
Jhdm1b, Lrh1, Sall4, and Glis1). Thus, JDP2 is a critical factor for
the determination of stemness. Here, we used iPSC technology
[24] with JDP2 and OCT4 to reprogram CS12 gastric cancer cells
to generate induced pluripotent cancer cells [25, 26], and found
a reduced tumorigenicity in CS12-derived iPSLCs, suggesting that
reprogramming of CS12 cells seems to abrogate the oncogenic
function of HOXA13 in CS12 cells [7]. Mechanically, although the
expression of HOXA13 was increased in both CS12 cells and
iPSLCs, HOXA13 behaved as an oncogene in CS12 but acted as a
tumor suppressor in iPSLCs through working with HOTTIP and
HOTAIR to up- and down-regulate BMP7 expression, respectively.
Knockdown of HOTTIP and BMP7 in CS12 cells decreased cancer-
ous features but downregulation of HOTAIR in iPLSCs promoted
cell proliferation. These results suggest that networking between
HOXA13 and lncRNAs can manipulate the oncogenic expression
of BMP7 in human gastric cancer cells.
MATERIALS AND METHODS
Cell Lines, Animals, Antibodies
Human gastric normal cells CSN and cancerous CS12 cells were
cultured as described elsewhere [27]. 293T, and mouse embryonic
ﬁbroblasts (MEFs) were obtained from the RIKEN Cell Bank
(Tsukuba, Ibaraki, Japan, http://cell.brc.riken.jp/en/) and cultured
in Dulbecco’s modiﬁed Eagle’s minimal essential medium
(DMEM; Gibco, Carlsbad, CA, https://www.thermoﬁsher.com)
supplemented with 10% charcoal-stripped fetal bovine serum
(FBS; Gibco) with or without 1% penicillin and streptomycin
(Gibco) as described elsewhere [7]. The animal welfare guide-
lines for the care and use of laboratory animals were approved
by the Animal Care Committee of the RIKEN BioResource Cen-
ter in Japan, the National Laboratory of Animal Center and the
Kaohsiung Medical University in Taiwan. All antibodies used in
this work are listed in Supporting Information Table S1.
Plasmids, Small Interference RNA, and Short Hairpin
RNA Lentivirus
The human HOXA13 and BMP7 cDNAs were obtained from the
RIKEN DNA Bank (IRAK168L10; Tsukuba, Ibaraki, Japan, http://
dna.brc.riken.jp/) and were inserted into pcDNA3 (ThermoFisher
Scientiﬁc, Waltham, MA, https://www.thermoﬁsher.com),
pPyCAG-GFP, or pPyCAG-IP [27], to generate expression plasmids
for cancer or stem cells. BMP7 promoter [–1,712 nucleotide (nt)
to1110 nt] was obtained from ActiveMotif (NM000522.4; Carls-
bad, CA, https://www.activemotif.com/) and was inserted into
pGL4 luciferase vectors (Promega, Madison, WI, https://www.
promega.com). The mutations of HOX binding sites (S1 to S3) at
BMP7 promoter were generated by polymerase chain reaction
using the primers of 50-CTTCGGAAGTAGCAGGCGCGGTGGA-30
(S1), 50-GCGTCAAGTGATAGCGTGAGTGAGTT-30 (S2), and 50-GTA
CCGAGCCTAGCCTAACTCCCTA-30 (S3). All constructs were con-
ﬁrmed by DNA sequencing. The short hairpin RNA (shRNA) lenti-
viruses were generated in 293T cells cotransfected with pCA
G-HIVgp-IN-D64V, pCMV-VSV-G-RSV-Rev, or pCMV-dR8.91, or
pCMV-d8.74pSPAX2 or VSVG/pMD2G, and TRCN0000355645 or
TRCN0000355646 (c-JUN), TRCN0000015405 or TRCN000001540
6 (HOXA13, Academia Sinica, Taipei, Taiwan, http://rnai.genmed.
sinica.edu.tw), PLKO.1-GFP (No. 30323; Addgene, Cambridge,
MA, https://www.addgene.org) or scrambled control shRNA
(Sigma-Aldrich, St. Louis, MO, https://www.sigmaaldrich.com)
[7]. Virus was puriﬁed at 72 hours after post-transfection as
described [28]. The CS12 cells (1 3 106) were infected with virus
at a multiplicity of infection (MOI) of 2 or 4. After cultivation for 3
days, cells were injected into severe combined immunodeﬁciency
(SCID) mice (5 3 106 cells/spot) as described elsewhere [29]. Len-
tiviruses for human BMP7-shRNA (SV-39748) and HOXA13-shRNA
(TR312365, TR312365) were obtained from Santa Cruz Biotech.
(Dallas, TX, https://www.scbt.com) and OriGene (Rockville, MD,
http://www.origene.com). For small interference RNA (siRNA)-
mediated gene knockdown, cells were transfected with siRNA
(ThermoFisher Scientiﬁc) against BMP7 (s2035, s2036, s2037),
HOXA13 (s6785, s6786, s6787), HOTTIP (n509686, n509687),
HOTAIR (n272221, n272230), c-JUN (s7659) [29], HOTAIRM1
(n507509, n507510), or negative control pool (s43418, s43420;
Dharmacon, D-001810–10-05) using Lipofectamine RNA iMAX
reagents (ThermoFisher Scientiﬁc). The effects on gene silencing
were examined after 48 hours of incubation.
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Generation of iPSLCs From Human Gastric Cancer Cell
Line CS12
The CS12 gastric cancer cells (5 3 105) were transfected with
OCT4 and JDP2 by electroporation as described elsewhere [30,
31]. The cells were then selected with G418 (100 mg/ml) for 2
days, and replated onto mitomycin C-treated MEFs in the stan-
dard iPS medium (DMEM [Gibco] supplemented with 10%
FBS and antimycotics-antibiotics [AM-AB; Gibco] plus human
leukemia inhibitoy factor [LIF; 10 ng/mL, ThermoFisher Scien-
tiﬁc]) [29, 31] for 2–3 weeks to obtain reprogrammed
iPSLCs. Alternatively, recombinant lentiviruses CSIV-CMV-MCS-
IRES2-Venus-encoding human OCT4 and JDP2 were gener-
ated using 293T cells. CS12 cells (5 3 104) were infected
with the lentiviruses (MOI5 2) and incubated for 1 week in
iPS medium with LIF as described above. Thereafter, cells
were transferred onto mitomycin C-treated MEFs in iPS
medium plus human LIF (10 ng/ml) to obtain reprogrammed
iPSLCs.
Cell Proliferation, BrdU-Incorporation, and Colony
Assay
The numbers of living cells were quantitated using a trypan
blue dye-exclusion assay [21, 29]. To analyze the cell cycle,
serum-starved cells were stimulated with 15% FBS and then
labeled with 10 lM BrdU (Sigma-Aldrich) for 1 hours, trypsi-
nized and ﬁxed overnight with 70% ethanol at 48C. The ﬁxed
cells were incubated in 2M HCl for 1 hours at room tempera-
ture, neutralized with 0.1 M Na2B4O5(OH)4.8H2O, stained by
BrdU antibody (BD Bioscience, San Jones, CA, http://www.
bdbiosciences.com) at room temperature for 2 hours, followed
by Alexa 488-conjugated secondary antibody at room tempera-
ture for 30 minutes. DNA was stained with propidium iodide
(PI; 5 mg/ml). Cell samples were analyzed with EPICS XL-MCL
ﬂow cytometer (Beckman Coulter, Miami, FL, https://www.
beckmancoulter.com). To quantitated the cells in S phase, the
BrdU Labeling and Detection Kit (Sigma-Aldrich) was used [29].
For the colony-formation assay, cells were plated in duplicate at
5 3 102 or 5 3 103 cells/10 cm gelatin-coated dish. Two weeks
later, colonies with a diameter > 2 mm were counted after
staining with Giemsa staining solution (Wako Chemicals, Tokyo,
Japan, http://www.wako-chem.co.jp/english/).
Teratoma, Tumor Formation, and
Immunohistochemistry
CS12 and CS12iPSLCs were injected subcutaneously into the
dorsal ﬂank of SCID mice as described [7, 29]. Tumor size was
measured once or twice a week using a caliper. Tumor volume
was estimated according to the formula: volume (cm3)5 (L 3
W2)/2, where L and W are the length and width of the tumor,
respectively. The teratomas were ﬁxed in 4% paraformalde-
hyde overnight and embedded in parafﬁn. Sections were
stained with hematoxylin and eosin.
Alkaline Phosphatase, Immunocytochemistry, and
Karyotyping
Alkaline phosphatase activity measurement and immunocyto-
chemistry were performed as described elsewhere [29, 30].
Chromosome spreads for karyotyping were prepared using a
conventional air-drying technique. GTG (G-banding) staining
was performed as described elswewhere [32].
Migration, Invasion, and Chemoresistance Assays
Cells (1 3 104 cells) resuspended in DMEM without FBS were
seeded in the upper Transwell with or without Matrigel (1 mg/
ml, Corning, NY, https://www.corning.com) as described else-
where [29]. The lower plate contained DMEM plus 10% FBS.
Three days later, the cells moved to downside of Transwell were
ﬁxed with 4% formaldehyde, stained with 1% crystal violet, and
counted under a microscope. Regarding chemoresistance assay,
cells were seeded in 96-well plates for 24 hours and then
treated with a serial mixture of cisplatin, 5-ﬂuorouracil, and
doxorubicin for additional 48 hours. Cell viability was examined
using the MTT assay as described elsewhere [21, 29].
Western Blotting
Western blotting was conducted as described elsewhere [7,
21]. Brieﬂy, cell lysates were prepared in SDS sample buffer
or Triton X-100 lysis buffer (10 mM HEPES, pH 7.8, 5% glyc-
erol, 1% Triton X-100, 5 mM EDTA, 50 mM NaF, 20 mM b-
glycerophosphate, 50 mg/ml aprotinin, 100 mM leupeptin, 25
mM pepstatin, 1 mM Na3VO4, and 1 mM PMSF), subjected to
SDS–PAGE, and electrotransferred onto a polyvinylidene
diﬂuoride membrane (Merck Millipore, Billerica, MA, https://
www.merckmillipore.com). After antibody incubation, ECL
immunodetection was performed. Results were analyzed using
a ChemiDoc XRSPlus analyzer (Bio-Rad, Hercules, CA, http://
www.bio-rad.com).
Reverse Transcriptase PCR and Quantitative
Polymerase Chain Reaction
Total RNA was extracted from cells using the TRIzol reagent
(ThermoFisher Scientiﬁc). RNA was reverse transcribed to cDNA
using a reverse transcription kit (Promega). PCR was performed
using the GoTaq Green Master Mix (Promega). Quantitative
polymerase chain reaction (qPCR) was performed using the
QuantiFast SYBR Green PCR kit (Qiagen, Gaithersburg, MD,
https://www.qiagen.com) as described elsewhere [7, 21]. b-
actin and GAPDH were used as internal controls. Primer
sequences are listed in Supporting Information Tables S2–S4.
Transient Transfection and Luciferase Assay
Transient transfection and the luciferase assay were per-
formed as described elsewhere [7, 21, 33–35]. Cells were
plated into each well of a 12-well plate and cultured for 24
hours. The cells were then cotransfected with indicated
amounts of various effector constructs and BMP7-promoter-
luciferase reporters using Lipofectamine 2000 (Invitrogen). The
total amount of transfected DNA was kept constant at 1 lg
per well by the addition of pBluescript. After 48 hours or the
indicated period of incubation, cells were harvested for lucif-
erase activity assay using Dual-Luciferase Reporter Assay Sys-
tem (Promega) and an illuminometer (Berthold Technologies,
Bad Wildbad, Germany, https://www.berthold.com).
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assay was performed
as described elsewhere [7, 29, 33]. The immunoprecipitated
protein–DNA complexes were washed twice with binding
buffer (10 mM HEPES, pH 7.9, 10 mM Tris-HCl, pH 7.9, 12.5%
glycerol, 0.25% NP-40, 0.5% Triton X-100, 0.24 M NaCl,
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0.75 mM MgCl2, 1.1 mM EDTA, and protease inhibitor mix-
ture) and then washed twice with Tris-EDTA buffer (10 mM
Tris-HCl, pH 7.9, and 1 mM EDTA). The protein–DNA com-
plexes were disrupted with proteinase K (Sigma-Aldrich) at pH
6.8. DNA was extracted with phenol and chloroform, precipi-
tated in ethanol, and analyzed by real-time PCR using the
Power SYBR Green Master Mix (Invitrogen). The PCR condi-
tions consisted of 1 cycle of 2 minutes at 508C and 1 cycle of
10 minutes at 958C followed by 40 cycles of 958C for 15 sec-
onds, and 558C2608C for 60 seconds. The primers used
in these experiments are shown in Supporting Information
Table S5.
RNA Immunoprecipiotation Assay
RNA immunoprecipiotation (RIP) assay was performed as
described elsewhere [36]. Cells were lysed in RIP lysis buffer
(10 mM HEPES, pH 8.0, 40 mM KCl, 3 mM MgCl2, 5% glyc-
erol, 2 mM DTT, 0.5% sodium deoxycholate, 100 unit/ml
RNase inhibitor and protease inhibitors) and the resulted cell
lysates (1 mg) were incubated with HOXA13 antibody for 2
hours, followed by 1 mg/ml tRNA-precleared protein A/G
beads for another 2 hours. The immunoprecipitates were
washed by RIP lysis buffer and resuspended in TRIzol reagent
(ThermoFisher Scientiﬁc) to extract the immunoprecipitated
RNA for reverse transcription and qPCR.
Statistical Analyses
The data are presented as the mean6 SEM from 3–6 experi-
ments. Difference between two and multiple experimental
groups was assessed using two-tailed Student’s t tests and
one-way ANOVA, respectively. Survival analysis was performed
using the Kaplan–Meier method with log-rank test. p< .05
was considered statistically signiﬁcant.
RESULTS
Comparative Expression of Stemness Genes in iPSLCs
and CS12 Cells
We used transcription factors, JDP2 and OCT4, to induce
reprogramming and generate iPSCs as described previously
[22], because it was not feasible to use the standard four
Yamanaka factors [24] to generate stem cell-like colonies
(data not shown) in the normal human gastric mucosa cell
line CSN and its derived CS12 cancer cells [7]. Three weeks
after electroporation of JDP2 and OCT4, small, packed, domed
iPSC-like colonies were detected (Fig. 1A). The number of col-
onies with a typical iPSC phenotype increased over time by
repetitive passage. When iPSLCs were cultured for more than
4 weeks, the CS12iPSLCs displayed strong alkaline phospha-
tase activity (Fig. 1A). qPCR revealed that the endogenous
expression of OCT4 and KLF4 in CS12iPSLCs increased about
3.4- and 5.3-fold, respectively, but NANOG and ESRRB were
repressed by 50% compared with CS12 cells (Fig. 1B). Endoge-
nous expression of JDP2 and p53 was also reduced by about
50% in CS12iPSLCs (Fig. 1B). RNA sequence analysis showed
that the primitive germ layer markers such as SOX1 (ecto-
derm), SOX17 (endoderm), and T (mesoderm) were not
changed between CS12 and CS12iPLSCs (Supporting Informa-
tion Fig. S1A); by contrast, the pluripotent markers ESRRB and
KLF2, but not REX1 and SALL4, were reduced by 30%–45% in
CS12iPSLCs (Supporting Information Fig. S1A). Immunoﬂuores-
cence staining conﬁrmed the expression of stemness markers
(OCT4, SOX2, NANOG, SSEA4, Tra-1–60, Tra-1–81) in
CS12iPSLCs (Fig. 1C). To conﬁrm the pluripotency [29], we
transferred CS12iPSLCs into SCID mice to generate teratomas,
which showed two germ layers such as endoderm and ecto-
derm (Fig. 1D). However, three germ layers were not
observed in any instance. These results suggest that
CS12iPSLCs were not fully pluripotent. The karyotype analysis
showed no changes of chromosomes in CS12iPSLCs (Support-
ing Information Fig. S1B).
CS12iPSLCs Exhibited Reduced Tumorigenicity In Vivo
To compare the tumorigenicity of CS12 and CS12iPSLCs, we
injected these cells subcutaneously into SCID mice. One
month after injection, tumors generated by CS12 cells
expanded to 2.5 cm3, which was 10 times the size of those
generated by CS12iPSLCs (Fig. 1E). Both sizes and weights of
tumors generated by CS12iPSLCs were smaller than those of
CS12 cells (Fig. 1F, 1G). CS12iPSLCs-derived xenografts exhib-
ited reduced numbers of necrotic cells and the cells with
large nucleus and mitosis (Fig. 1E). Thus, CS12iPSLCs exhibited
reduced tumorigenicity in vivo when compared with CS12
cells.
Decreased Cell Proliferation, Colony Formation, Cell
Migration and Invasion, and Drug Resistance in
CS12iPSLCs
To verify the difference in oncogenic activity between CS12
and CS12iPSLCs, cell proliferation, colony formation, cell
migration, invasion, and drug resistance were examined. The
CS12 cells proliferated more rapidly than CS12iPSLCs and
CSN cells (Fig. 2A). The colony-forming ability of CS12 cells
was twofold higher than that of CS12iPSLCs (Fig. 2B). Cell
cycle analysis of bromodeoxyuridine (BrdU)-labled cells and
BrdU ELISA assay conﬁrmed that cell proliferation of
CS12iPSLCs was reduced (Fig. 2C). No increase in apoptosis
was found in CS12iPSLCs (Supporting Information Fig. S1C).
Transwell assays demonstrated that both the migration and
invasion efﬁcacies of CS12 cells were higher than those of
CS12iPSLCs and CSN cells (Fig. 2D), which were consistent
with the increased expression of Snail 1 family transcrip-
tional repressor 1/2 (Snail1/2), Matrix metalloproteinase 2
(MMP2), Vimentin, and with the decrease of E-CADHERIN in
CS12 cells (Supporting Information Fig. S1D, S1E). To exam-
ine the drug resistance, cell viability was measured by incu-
bating cells with a mixture of three conventional drugs for
chemotherapy: 5-ﬂuorouracil, cisplatin, and doxorubicin.
CS12 cells showed greater resistance to these drugs than
CS12iPSLC and CSN cells (Fig. 2E), demonstrating the
increased chemoresistance of CS12 cells.
Enhanced Expression of HOXA13 in CS12iPSLCs and
CS12 Cells
We previously reported that several HOXA genes were upre-
gulated in CS12 when compared with CSN cells [37] and upre-
gulated HOXA13 contributed to the tumorigenicity of CS12
cells [7]. Here, we found that the expressions of HOXA4, 5, 7,
and 9 were decreased in CS12iPSLCs when compared with
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Figure 1. Generation and tumorigenicity of iPSLCs from CS12 gastric cancer cells. (A): Schematic representation of iPSLCs generation
from CS12 cells by OCT4 and JDP2. Morphology (CS12 and CS12iPSLCs) and alkaline phosphatase staining (CS12iPSLCs) are shown (mag-
niﬁcation, 3100). (B): Expression of stemness genes analyzed by quantitative reverse transcriptase PCR (RT-PCR). The plot shows the
mean (n5 5)6 SEM (*, p< .05; **, p< .01). (C): Immunocytochemical analysis of pluripotency markers in CS12iPSLCs (magniﬁcation,
3200). (D): (Left panel) Pluripotency of CS12iPSLCs. Teratomas that were generated by the transplantation of CS12iPSLCs into severe
combined immunodeﬁciency (SCID) mice were examined by immunohistochemistry, which shows differentiation of the ectoderm (kerati-
nocytes) and endoderm (glandular cells). White bar, 100 lm. (Right panel) Expression of differentiation marker genes were examined by
quantitative RT-PCR. The plot shows the mean (n5 5)6 SEM (*, p< .05). (E): Tumor formation of subcutaneously injected CS12 and
CS12iPSLCs in SCID mice. Tumor was sectioned and stained with hematoxylin and eosin (scale bar, 50 lm). (F): Tumor sizes of CS12 and
CS12iPSLCs. The plot shows the mean (n5 5)6 SEM (**, p< .01). (G): Tumor weight of CS12 and CS12iPSLCs. Plot shows the mean
(n5 5)6 SEM (**, p< .01). Abbreviations: MEFs, mouse embryonic ﬁbroblasts iPS, induced pluripotent stem; LIF, leukemia inhibitoy fac-
tor; iPSLCs, induced pluripotent stem cell-like cells; JDP2, Jun dimerization protein 2; OCT4, octamer-binding protein 4.
CS12 cells (Fig. 3A; Supporting Information Figure S2A). Unex-
pectedly, HOXA13 was further increased in CS12iPSLCs (Fig.
3A, 3B; Supporting Information Figure S2A), implying that
other factors might be involved in determining the oncogenic
activity of HOXA13.
To clarify the effects of HOXA13 on the different tumor-
igenicity between CS12 and CS12iPSLCs, HOXA13-knockdown
CS12 cells (Fig. 3C), and CS12iPSLCs (Fig. 3E) were inocu-
lated into SCID mice to compare xenograft formation ability.
Knockdown of HOXA13 in CS12 cells decreased tumor
Figure 2. Comparison of in vitro cancer features of CSN, CS12, and CS12iPSLCs. (A): Cell growth of CSN, CS12, and CS12iPSLCs
was determined using trypan blue dye-exclusion test (n5 5). (B): Colony formation of CSN, CS12, and CS12iPSLCs. Cells were plated
in gelatin-coated dishes and colonies with a diameter> 2 mm were counted 2 weeks later. (C): (Upper panels) BrdU incorporation
assay. x-axis indicates DNA contents (PI) and y-axis indicates BrdU intensity. Cell populations at G1, S, and G2/M phases were
shown in Tables (Lower panel), BrdU-incorporation and ELISA assay using the BrdU Labeling and Detection Kit I (Sigma-Aldrich).
Data are presented as means (n5 3)6 SEM, **, p< .01. (D): The degrees of invasion and migration were analyzed by Transwell
with and without Matrigel, respectively. (E): The drug-resistance capacities of CSN, CS12, CS12iPSLCs were demonstrated by the sur-
vival rates of cells treated with 5-Fu, Cis, and Dox. Data are presented as means (n5 3)6 SEM, *, p< .05; **, p< .01. Abbrevia-
tions: 5-Fu, 5-ﬂuorouracil; BrdU, bromodeoxyuridine; Cis, cisplatin; Dox, doxorubicin; iPSLCs, induced pluripotent stem cell-like cells;
PI, propidium iodide.
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Figure 3. Role of HOXA13 in tumor formation of CS12 and CS12iPSLCs xenografts. (A): Comparative mRNA expressions of HOXA family
genes in CS12 and CS12iPSLCs were examined by quantitative reverse transcriptase PCR. The data are presented as mean6 SEM. Rela-
tive expression of HOXA mRNA in CS12 cells was set as one. (B): Comparative expression of HOXA13 proteins in CSN, CS12, and
CS12iPSLCs. The exposure time is 100 seconds. Data are presented as means (n5 3)6 SEM, *, p< .05. (C): Expression of HOXA13 was
examined by Western blot in CS12 cells treated with siRNA against HOXA13, c-JUN, or scramble control. The exposuire time was 50 sec-
onds. (D): The effect of HOXA13 knockdown on tumor growth of CS12 xenografts. (E): Comparative expression of HOXA13 was examined
by Western blot in CS12iPSLCs treated with siRNA against HOXA13, c-JUN, or scramble control. The exposure time is 50 seconds. (F):
The effects of HOXA13 knockdown on tumor growth of CS12iPSLCs xenografts. (G, H): The effects of HOXA13 knockdown on tumor sizes
of CS12 (G) and CS12iPSLCs (H) xenografts. (I, J): The effects of HOXA13 knockdown on tumor weights of CS12 (I) and CS12iPSLCs (J)
xenografts. All data in (G–J) were derived from six independent experiments and are presented as mean6 SEM (**, p< .01). Abbrevia-
tion: iPSLCs, induced pluripotent stem cell-like cells.
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formation and tumor weight (Fig. 3D, 3G, 3I). In contrast,
HOXA13-knockdown CS12iPSLCs increased tumor size and
tumor weight (Fig. 3F, 3H, 3J). These data support the
notion that HOXA13 in conjunction with some unspeciﬁed
factors determined the tumorigenicity of CS12 cells and
CS12iPSLCs.
Differential Expressions of BMP7 and lncRNAs were
Critical to Determine the Tumorigenicity of CS12 Cells
and CS12iPSLCs
To further characterize the differences between CS12 and
CS12iPSLCs, we examined the expression proﬁles of CS12 and
CS12iPSLCs using RNA sequencing and conﬁrmed that BMP7, a
known HOXA13 target [8, 9], was upregulated in CS12
compared with that in CS12iPSLCs (Fig. 4A; Supporting Informa-
tion Fig. S3B). Expressions of BMP7 protein and phosphorylated
SMAD1 protein were indeed upregulated in CS12, suggesting
the crosstalk of BMP7-SMAD axis [9] (Supporting Information
Fig. S2B). BMP7 might be critical because it was altered signiﬁ-
cantly in several gene ontology categories, such as stem cancer
stem, pluripotent stem progenitors, epithelial-mesenchymal
transition (EMT)/mesenchymal-epithelial transition (MET), cyto-
kines, and growth factors (Supporting Information Fig. S3B).
Knockdown of HOXA13 but not c-JUN (as a control) in CS12
cells decreased BMP7 protein level (Supporting Information Fig.
S3A). Expressions of other HOXA13 targets including BMP2,
insulin-like growth factor-binding protein 3 and annexin A2 as
well as FGF8 were not changed (Fig. 4A).
We also found the preferential upregulation of HOTTIP in
CS12 cells and HOTAIR in CS12iPSLCs, respectively, (Fig. 4B).
The expression of another HOXA transcript antisense RNA,
myeloid-speciﬁc 1 (HOTAIRM1) expression was unchanged
(Fig. 4B). Because HOTTIP and HOTAIR regulate expression of
HOX gene clusters, and HOXA13 controls BMP7 expression, we
next examine the role of HOTTIP/HOTAIR–HOXA13–BMP7 axis in
tumorigenicity by knockdown experiments (Fig. 4C, 4D).
In CS12 cells, siHOTTIP reduced the expression of HOXA13
as reported [6, 12, 14], but siHOTAIR did not affect the
expression of HOXA13. By contrast, in CS12iPSLCs, siHOTTIP
did not affect the expression of HOXA13, but siHOTAIR
decreased the expression of HOXA13 (Supporting Information
Fig. S4A). In CS12 cells, knockdown of BMP7 and HOTTIP, but
not HOTAIR, decreased cell growth, colony formation, cell
migration and invasion activity (Fig. 4E–4H), suggesting that
HOTTIP and BMP7 contribute to the tumorigenicity of CS12
cells. Conversely, knockdown of HOTAIR, but not BMP7, in
CS12iPSLCs, increased cell growth, colony formation, cell
migration, and invasion activity (Fig. 4E–4H), indicating that
HOTAIR played a tumor suppressor role in CS12iPSLCs. Knock-
down of HOXA13 resulted in a reduced cell growth in CS12
cells but caused an increase of cell proliferation in CS12iPSLCs
(Fig. 4E), which was consistent with the results of mouse
xenograft model (Fig. 3). The reduced tumorigenicity of
CS12iPSLCs was also associated with restored expressions of
p53 and several CDK inhibitors including p16Ink4a, p15Ink4b,
p18Inc4c, p21Cip1, p27Kip1, and p57Kip2, together with decreased
E2F-1 expression in CS12iPSLCs compared with that in CS12
cells (Supporting Information Fig. S4B).
On the other hand, overexpression of BMP7 in CS12iPSLCs
increased cell proliferation, colony formation, and cell migra-
tion and invasion (Supporting Information Fig. S5A–S5E). The
in vivo tumorigenicity of BMP7-transduced CS12iPSLCs
showed increased tumor incidence and mortality compared
with that of control cells (Supporting Information Fig. S5F,
S5G). Blood vessels, giant cells, mitotic cells, and necrosis
were also detected signiﬁcantly in the tumors derived from
BMP7-transformed CS12iPSLCs (data not shown).
Differential Recruitment of HOXA13 to the BMP7
Promoter at S1 and S2 Sites in CS12 and CS12iPSLCs,
Respectively
Given that BMP7 was differentially expressed in CS12 and
CS12iPSLCs (Fig. 4A, Supporting Information Fig. S2B, S3B),
and was critical for determining the tumorigenicity of both
cells (Fig. 4E–4H), and forced expression of BMP7 enhanced
tumorigenic features in CS12iPSLCs (Supporting Information
Fig. S5), we investigated how BMP7 expression was regulated
in both cells. It is known that HOXA13 directly binds to the
BMP7 promoter and induces BMP7 expression [9, 38, 39]. We
conducted ChIP assays to examine the binding of HOXA13 to
the BMP7 promoter in CS12iPSLCs and CS12 cells. Computa-
tional sequence analysis revealed three putative HOX-binding
sites: S1 (–412/–416), S2 (–1,113/–1,117), and S3 (–1,613/–
1,617) in the BMP7 promoter (Fig. 5A) (PROMO3; TRANSFAC
v8.3) [40]. The results of ChIP showed that recruitment of
HOXA13 to the S1 site was increased in CS12 cells but not in
CS12iPSLCs. By contrast, binding of HOXA13 to the S2 site
was increased in CS12iPSLCs but not in CS12 cells (Fig. 5A).
No signiﬁcant recruitment of HOXA13, HOXA9, or HOXA7 was
found at the S3 site and nonspeciﬁc NS site. In addition, ChIP
assays demonstrated an elevated trimethylation of lysine 4 on
histone H3 (H3K4me3) and an increased recruitment of MLL1/
WDR5 at the S1 site in CS12 cells, but not in CS12iPSLCs (Fig.
5B), indicative of activated BMP7 promoter in CS12 cells. By
contrast, increased H3K27me3 and recruitments of EZH2 and
jumonji AT-rich interactive domain 2 (JARID2) [41] were found
at the S2 site in CS12iPSLCs, but not in CS12 cells (Fig. 5B),
explaining the reduced BMP7 expression in CS12iPSLCs. No
signiﬁcant difference in these epigenetic marks was observed
at the S3 and NS sites in both cells (Fig. 5B). The expression
levels of Polycomb group RING ﬁnger complex protein B lym-
phoma Mo-MLV insertion region 1 homolog (BMI1), EZH2,
SUZ12, and JARID2 were signiﬁcantly higher in CS12iPSLCs
than in CS12 cells (Supporting Information Fig. S6). Moreover,
an RNA immunoprecipitation experiment [36] demonstrated
that the association between HOXA13 and HOTTIP was pre-
dominant in CS12; by contrast, HOTAIR-HOXA13 interactioon
is evident in CS12iPSLCs (Fig. 5C). These ﬁndings suggested
that the differential recruitment of HOXA13 was correlated
with contrasting epigenetic marks at the S1 and S2 sites of
the BMP7 promoter and conversed expression patterns of
BMP7 in CS12 cells and CS12iPSLCs.
HOXA13 Differentially Upregulates and Downregulates
BMP7 Promoter Activity Through the S1 and S2 Sites,
Respectively
To further examine the roles of S1 and S2 sites in HOXA13-
mediated BMP7 expression, we cloned BMP7 promoters, both
wild-type and HOX-binding site mutants, into a luciferase
reporter plasmid (Fig. 6A) and then cotransfected them with
a HOXA13-expressing plasmid into CS12 cells. The results
showed that HOXA13 transactivated wild-type and S2- and S3-
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Figure 4. Identiﬁcation of BMP7 and long noncoding RNAs as critical determinants of tumorigenicity. (A): Comparative mRNA expres-
sion of FGF8, BMP2, BMP7, IGFBP-3, ANXA2, and IL-6 in CSN, CS12, and CS12 iPSLCs was examined by quantitative reverse transcriptase
PCR (RT-PCR). (B): Comparative expression of HOTTIP, HOTAIR, and HOTAIRM1 in CSN, CS12, and CS12iPSLCs was examined by quantita-
tive RT-PCR. (C): Knockdown of GFP, HOTTIP, or HOTAIR by respective siRNAs in CS12 cells (left) and CS12iPSLCs (right). (D): Knockdown
of BMP7 was examined by Western blot in CS12 (left) and CS12iPSLCs (right). The exposure time is 100 seconds (left) and 200 seconds
(right), respectively. (E): Effect of siRNA against HOXA13, HOTTIP, HOTAIR, or BMP7 on cell proliferation of CS12 (left) and CS12iPSLCs
(right) was examined by trypan blue dye-exclusion test. (F): Effect of siRNA against HOTTIP, HOTAIR, or BMP7 on colony formation of
CS12 (left) and CS12iPSLCs (right). (G): Effect of siRNA against HOTTIP, HOTAIR, or BMP7 on cell migration of CS12 (left) and CS12iPSLC
(right). (H): Effect of siRNA against HOTTIP, HOTAIR, or BMP7 on cell invasion of CS12 (left) and CS12iPSLC (right). All data are presented
as mean6 SEM (n5 5; *, p< .05; **, p< .01). Abbreviations: BMP7, bone morphogenetic protein 7; HOTTIP, HoxA transcript at the dis-
tal tip; HOTAIR, HoxA transcript antisense RNA; iPSLCs, induced pluripotent stem cell-like cells.
mutated BMP7 promoters comparably, but just marginally
induced S1-mutated BMP7 promoter (Fig. 6B), supporting that
HOXA13 induced BMP7 expression through S1 site in CS12
cells. To examine the effect of HOXA13 on BMP7 promoter in
iPSLCs, we used a feasible promoter (pPyCAG) to drive
HOXA13 expression in stem cells [35]. The results showed that
Figure 5. Differential epigenetic states of BMP7 promoter in CS12 and CS12iPSLCs. (A): Schematic representation of BMP7 promoter and the
putative HOX-binding sites: S1, S2, and S3. Q-PCR primers for chromatin immunoprecipitation (ChIP) assay are denoted by arrows, including a
NS site. ChIP–qPCR analyses of HOXA7, HOXA9, HOXA13, and IgG (negative control) were performed using CS12 (open bar) and CS12iPSLCs
(solid bar) lysates. Input; 5% DNA. (B): ChIP–qPCR analyses using antibodies against methylated histones, WDR5–MLL complex, PRC2 complex,
and JARID2 were performed in CS12 and CS12iPSLCs. Input: 5% DNA. The data are presented as mean6 SEM (n5 5; **, p< .01). (C): RNA
immunoprecipitation (RIP) assay. CS12 and CS12iPSLC lysates were incubated with antibody against HOXA13 or control IgG, and then precipitates
by protein A/G beads. The RNA in the immunoprecipitates was extrcated using TRIzol and was subjected to quantitative reverse transcriptase
PCR to detect the HOXA13-bound HOTTIP, and HOTAIR. b-actin RNA serves as a negative control. The relative intensity of binding was normal-
ized by that of IgG and the data was shown as mean6 SEM (n5 5). Abbreviations: BMP7, bone morphogenetic protein 7; HOTAIR, HoxA tran-
script antisense RNA; HOTTIP, HoxA transcript at the distal tip; iPSLCs, induced pluripotent stem cell-like cells; NS, nonspeciﬁc.
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only S2 mutant displayed increased activity but all other
mutants and wild type BMP7 promoter constructs showed
signiﬁcant repression in CS12iPSLCs (Fig. 6C), suggesting that
HOXA13 inhibited BMP7 expression through S2 site.
HOTTIP– and HOTAIR–Differentially Regulated BMP7
Promoter Activity and the Epigenetic Configurations at
S1 and S2 Sites
Because HOTTIP and HOTAIR regulate gene expression
through MLL–WDR5 and PRC2–EZH2 complexes, respectively
[12, 17, 42], we examined the effects of siHOTTIP and siHO-
TAIR on the recruitments of MLL–WDR5 and SUZ–EZH2–
JARID2 to the BMP7 promoter in CS12 and CS12iPSLCs. The
results showed that knockdown of HOTTIP, but not HOTAIR,
reduced H3K4me3 and decreased the recruitment of MLL/
WDR5 to the S1 site in CS12 cells (Fig. 7A), suggesting that
HOTTIP knockdown might decrease BMP7 promoter activity.
Knockdown of HOTAIR, but not HOTTIP, reduced H3K27me3
and decreased the recruitment of EZH2 and JARID2 to the S2
site of the BMP7 promoter in CS12iPSLCs (Fig. 7B), indicating
that HOTAIR contributed to the suppressive conﬁguration at
the S2 site. The knockdown of HOXA13 also showed similar
patterns of HOTTIP–MLL–WDR5 axis in CS12 cells and
HOTAIR–EZH2–JARID2 axis in CS12iPSLCs (Fig. 7A, 7B). Indeed,
knockdown of HOTTIP or HOXA13 decreased BMP7 promoter
activity in CS12 cells (Fig. 7C), while HOTAIR knockdown
increased BMP7 promoter activity in CS12iPSLCs (Fig. 7D).
These ﬁndings demonstrated that HOTTIP upregulated BMP7
expression in CS12, but HOTAIR suppressed BMP7 expression
in CS12iPSLCs, both were involved with HOXA13 (Fig. 7E).
DISCUSSION
In this study, we reprogrammed the human gastric cancer cell
line CS12 using OCT4 and JDP2 to generate CS12iPSLCs (Fig.
1). This technique is useful for cellular reprogramming of
somatic cells and cancer cells into stem cells or stem-like cells,
which can serve as disease model or a platform for drug
screening. Notably, the reprogrammed CS12iPSLCs exhibited
less tumor formation capacity in SCID mice when compared
with the parental CS12 cells (Fig. 1E–1G), suggesting that
reprogramming of cancer cells may be a strategy that could
be developed for the future therapy.
Accumulating evidence reveals that high-level expression
of BMP7 correlates with increased invasion and metastasis
Figure 6. HOXA13 regulates BMP 7 promoter through HOX-binding sites. (A): Schematic representation of BMP7 promoter luciferase
constructs containing WT or mutations at the putative HOX binding sites (S1 to S3). (B): HOXA13 transactivated BMP7 promoter through
S1 site in CS12 cells. (C): HOXA13 repressed BMP7 promoter through S2 site in CS12iPSLCs. Various BMP7 promoter luciferase constructs
were cotransfected with pcDNA3-HOXA13 into CS12 cells (B) or pPyCAG-FLAG-HOXA13 into CS12iPSLCs (C) for 48 hours, and then the
luciferase activity was measured. The data are presented as mean6 SEM (n5 5; **, p< .01). Abbreviations: WT, wild type; iPSLCs,
induced pluripotent stem cell-like cells.
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Figure 7. Regulation of epigenetic conﬁguration and BMP7 promoter activity by siRNA against HOTTIP, HOTAIR, and HOXA13. (A, B):
Effect of siRNA against GFP, HOTTIP, HOTAIR, and HOXA13 on histone methylations and recruitments of WDR5-MLL1, and PRC2 com-
plexes to the S1 and NS sites in CS12 cells (A) or to the S2 site and NS sites in CS12iPSLCs (B). (C, D): Effects of siHOTTIP, siHOTAIR, and
siHOXA13 on BMP7 promoter activities in CS12 (C) and CS12iPSLCs (D), respectively. The untreated BMP7 promoter activity in CS12 cells
was assigned as one. The data are presented as mean6 SEM (n5 5; **, p< .01). (E): Schematic representation of the role of HOXA13-
HOTTIP axis and HOXA13-HOTAIR axis on the BMP7 promoter in CS12 and CS12iPSLCs. K4me3; histone H3K4me3, K27me3; histone
H3K27me3. Trithorax complex is composed of MLL, WDR and other components including JARID2. Polycomb repressive complex 2 is
composed of SUZ12, EZH2 and other components. Abbreviations: BMP7, bone morphogenetic protein 7; HOTAIR, HoxA transcript anti-
sense RNA; HOTTIP, HoxA transcript at the distal tip; OCT4, octamer-binding protein 4.
[43], cartilage and bone repair [44], programmed cell death
[45], and various cancers including gastric cancer [43, 46]. Our
knockdown experiments also supported an essential role of
BMP7 in promoting cell proliferation, migration, invasion, and
colony formation in CS12 cells (Fig. 4E–4H). Moreover, we
found that forced expression of BMP7 in CS12iPSLCs, whose
BMP7 level was low, increased oncogenic phenotypes such as
xenograft tumor formation in SCID mice, invasive and migra-
tory activity, colony formation and cell proliferation (Support-
ing Information Fig. S5). These results indicate that, at least in
gastric cancer, BMP7 behaves as an oncogene.
Our results demonstrated the importance of the HOTTIP/
HOTAIR–BMP7 axis in gastric cancer (Fig. 4E–4H). In particular,
the increase of tumorigenicity in CS12iPSLCs by HOTAIR knock-
down suggests that HOTAIR is a tumor suppressor gene as
previously reported in glioblastoma and pediatric ependy-
moma [47, 48]. However, some studies suggest that HOTAIR is
more likely to be an oncogene [42, 49, 50]. Thus, the precise
role of HOTAIR may be context-dependent.
The differential recruitment of HOXA13 at positive and
negative regulatory sites of the BMP7 promoter is a new ﬁnd-
ing, which demonstrates that HOXA13 can play either a posi-
tive or a negative role in expression of the same gene. Most
previous studies only show the oncogenic role of HOXA13.
Our study reveals that HOXA13 has an anti-oncogenic activity
in CS12iPSLCs possibly through suppressing BMP7 expression
(Figs. 3F, 3H, 3J, 6C, 7D). This study also demonstrates a
novel, opposing regulation of the BMP7 expression pattern,
which is regulated by HOTTIP- and HOTAIR-mediated epige-
netic changes at the S1 and S2 sites of BMP7 promoter,
respectively (Fig. 7). These epigenetic changes are differen-
tially regulated in CS12 and CS12iPSLCs, which represent dif-
ferent gastric cancer stages. Thus, the present study reveals
the complexity of epigenetic regulation of BMP7 expression
during the development of gastric cancer.
This study has identiﬁed the differential effects of HOTTIP
and HOTAIR on the S1 and S2 sites of BMP7 promoter that is
correlated with upregulated and downregulated BMP7 expres-
sion, respectively. However, this ﬁnding does not fully explain
the differential HOXA13 binding of S1 and S2 sites that is also
correlated with BMP7 expression. Several issues need further
investigation. First, the recruitment of HOXA13 at the S1 and
S2 sites after knockdown of HOTTIP and HOTAIR can be exam-
ined to show the effect of lncRNAs on HOXA13 recruitment
to the BMP7 promoter. Second, whether HOTTIP and HOTAIR
directly target to S1 and S2 sites, respectively, or HOTTIP and
HOTAIR regulate epigenetic changes at S1 and S2 sites indi-
rectly is still unclear. Although our data showed the increased
recruitment of WDR5/MLL to the HOTTIP-regulated S1 site
and EZH2/JARID2 to the HOTAIR-regulated S2 site (Fig. 5), we
did not yet check the presence of HOTTIP and HOTAIR at
these sites. Third, if HOTTIP and HOTAIR are recruited to the
S1 and S2 sites, is HOXA13 involved in this recruitment?
Moreover, is HOXA13 required for HOTTIP and HOTAIR recruit-
ment? The interactions between HOXA13 and HOTTIP–
HOTAIR, either directly or through other factors such as
WDR5 and EZH2/SUZ12, remain to be examined, although
they are associated each other (Fig. 5C). We are exploring
these questions to elucidate more comprehensively the mech-
anism underlying BMP7 expression regulated by HOXA13–
HOTTIP–HOTAIR in different settings.
CONCLUSION
Here, we have identiﬁed BMP7 as the key target of HOXA13
to control cell growth, invasion, and migration of human gas-
tric cancer cells. In addition to BMP7, the ﬁnding of involve-
ment of the histone methyltransferase (HMT) MLL and EZH2
in regulating BMP7 expression has revealed potential targets
for cancer therapy. Several HMT inhibitors are under develop-
ment to inhibit MLL and EZH2-SUZ12 for therapeutic purpose.
Thus, the MLL–WDR5–HOTTIP–HOXA13 axis in CS12 cells can
be used to test the therapeutic efﬁcacy of HMT inhibitors.
Furthermore, the EZH2–JARID2–HOTAIR–HOXA13 axis in
CS12iPSLCs provides a platform to screen carcinogens that
increase BMP7 expression.
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